Paper3207553
Delayed-release mesalazine (5-aminosalicylic acid): coat dissolution and excretion in ileostomy subjects.
Riley SA and 3 others. Br J Clin Pharmacol, 1988. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Delayed-release mesalazine (5-aminosalicylic acid): coat dissolution and excretion in ileostomy subjects. Papers, record 3207553. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3207553
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Delayed-release mesalazine (5-aminosalicylic acid): coat dissolution and excretion in ileostomy subjects.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminosalicylic Acids | Major topic |
| Ileostomy | Major topic |
| Adult | |
| Chemistry, Pharmaceutical | |
| Delayed-Action Preparations | |
| Female | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Male | |
| Mesalamine | |
| Middle Aged | |
| Solubility |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5937767 | Ionic constituents and osmolality of gastric and small-intestinal fluids after eating. | Am J Dig Dis | 1966 | https://conductscience.org/library/papers/5937767 | PubMed |
| 2 | 4146729 | Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4146729 | PubMed |
| 3 | 4448417 | Effects of lactulose and other laxatives on ileal and colonic pH as measured by a radiotelemetry device. | Gut | 1974 | https://conductscience.org/library/papers/4448417 | PubMed |
| 4 | 72239 | An experiment to determine the active therapeutic moiety of sulphasalazine. | Lancet | 1977 | https://conductscience.org/library/papers/72239 | PubMed |
| 5 | 36326 | Small bowel absorption of sulfasalazine and its hepatic metabolism in human beings, cats, and rats. | Gastroenterology | 1979 | https://conductscience.org/library/papers/36326 | PubMed |
| 6 | 36332 | Influence of intestinal transit time on azo-reduction of salicylazosulphapyridine (Salazopyrin). | Gut | 1979 | https://conductscience.org/library/papers/36332 | PubMed |
| 7 | 14238045 | PREDNISONE AS MAINTENANCE TREATMENT FOR ULCERATIVE COLITIS IN REMISSION. | Lancet | 1965 | https://conductscience.org/library/papers/14238045 | PubMed |
| 8 | 7126413 | An oral preparation to release drugs in the human colon. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7126413 | PubMed |
| 9 | 6615691 | Colonic release of 5-amino salicylic acid from an oral preparation in active ulcerative colitis. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6615691 | PubMed |
| 10 | 6661362 | Kinetics of 5-aminosalicylic acid after jejunal instillation in man. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6661362 | PubMed |
| 11 | 6675167 | Absorption and excretion of a single 1-g dose of azodisal sodium in subjects with ileostomy. | Scand J Gastroenterol | 1983 | https://conductscience.org/library/papers/6675167 | PubMed |
| 12 | 3979912 | Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion. | Gut | 1985 | https://conductscience.org/library/papers/3979912 | PubMed |
| 13 | 13865153 | Sulphasalazine and salicylazosulphadimidine in ulcerative colitis. | Lancet | 1962 | https://conductscience.org/library/papers/13865153 | PubMed |
| 14 | 6127096 | Azo reduction of sulphasalazine in healthy volunteers. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/6127096 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26883035 | Investigation of a High-Dose pH-Dependent-Release Mesalazine on the Induction of Remission in Active Crohn's Disease. | Drugs R D | 2016 | https://conductscience.org/library/papers/26883035 | PubMed |
| 25478568 | Therapeutic efficacy of pH-dependent release formulation of mesalazine on active ulcerative colitis resistant to time-dependent release formulation: analysis of fecal calprotectin concentration. | Biomed Res Int | 2014 | https://conductscience.org/library/papers/25478568 | PubMed |
| 20049950 | Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: a double-blind, randomized study. | Inflamm Bowel Dis | 2010 | https://conductscience.org/library/papers/20049950 | PubMed |
| 20049949 | Direct comparison of two different mesalamine formulations for the maintenance of remission in patients with ulcerative colitis: a double-blind, randomized study. | Inflamm Bowel Dis | 2010 | https://conductscience.org/library/papers/20049949 | PubMed |
| 18484800 | Improving delivery of aminosalicylates in ulcerative colitis: effect on patient outcomes. | Drugs | 2008 | https://conductscience.org/library/papers/18484800 | PubMed |
| 11247905 | Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs. | Gut | 2001 | https://conductscience.org/library/papers/11247905 | PubMed |
| 9723828 | Mesalazine release from a pH dependent formulation: effects of omeprazole and lactulose co-administration. | Br J Clin Pharmacol | 1998 | https://conductscience.org/library/papers/9723828 | PubMed |
| 8504969 | Oroileal transit of slow release 5-aminosalicylic acid. | Gut | 1993 | https://conductscience.org/library/papers/8504969 | PubMed |
| 2684592 | Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease. | Drugs | 1989 | https://conductscience.org/library/papers/2684592 | PubMed |
| 2199130 | Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II). | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/2199130 | PubMed |
| 1550697 | Prandial and diurnal effects on the absorption of orally administered enteric coated 5-aminosalicylic acid (5-ASA). | Br J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1550697 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3207553
GET https://conductscience.org/api/papers/v1/3207553/authors